Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PPARG Antikörper

PPARG Reaktivität: Human WB, ELISA, IF Monoclonal unconjugated
Produktnummer ABIN966888
  • Target Alle PPARG Antikörper anzeigen
    PPARG (Peroxisome Proliferator-Activated Receptor gamma (PPARG))
    Reaktivität
    • 156
    • 109
    • 96
    • 34
    • 33
    • 24
    • 22
    • 20
    • 15
    • 10
    • 6
    • 6
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    Bitte anfragen
    Klonalität
    • 153
    • 19
    Monoklonal
    Konjugat
    • 85
    • 14
    • 11
    • 7
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    Dieser PPARG Antikörper ist unkonjugiert
    Applikation
    • 154
    • 60
    • 55
    • 52
    • 52
    • 31
    • 22
    • 16
    • 14
    • 13
    • 7
    • 5
    • 5
    • 4
    • 2
    • 1
    Western Blotting (WB), ELISA, Immunofluorescence (IF)
    Spezifität
    Ni-NTA purified truncated recombinant PPARG expressed in E. Coli strain BL21 (DE3).
    Aufreinigung
    Crude ascites.
    Isotyp
    IgG1
    Top Product
    Discover our top product PPARG Primärantikörper
  • Applikationshinweise
    Western Blot: 1: 500- 1: 2,000
    IF: 1:200- 1:1000
    ELISA: Propose dilution 1: 10,000 Determining optimal working dilutions by titration test.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Lagerung
    -20 °C
  • Yang, Ma, Ma, Fogo: "Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis." in: Kidney international, Vol. 69, Issue 10, pp. 1756-64, (2006) (PubMed).

    Weng, Chen, Pinzone, Ringel, Chen: "Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones." in: Endocrine-related cancer, Vol. 13, Issue 2, pp. 401-13, (2006) (PubMed).

    Ahdjoudj, Kaabeche, Holy, Fromigué, Modrowski, Zérath, Marie: "Transforming growth factor-beta inhibits CCAAT/enhancer-binding protein expression and PPARgamma activity in unloaded bone marrow stromal cells." in: Experimental cell research, Vol. 303, Issue 1, pp. 138-47, (2004) (PubMed).

  • Target
    PPARG (Peroxisome Proliferator-Activated Receptor gamma (PPARG))
    Andere Bezeichnung
    PPARG (PPARG Produkte)
    Synonyme
    PPAR gamma antikoerper, PPARg2 antikoerper, PPARG antikoerper, Nr1c3 antikoerper, PPAR-gamma antikoerper, PPAR-gamma2 antikoerper, PPARgamma antikoerper, PPARgamma2 antikoerper, NR1C3 antikoerper, CIMT1 antikoerper, GLM1 antikoerper, PPARG1 antikoerper, PPARG2 antikoerper, xPPAR-gamma antikoerper, PPAR-GAMMA antikoerper, PPARGAMMA antikoerper, peroxisome proliferator-activated receptor gamma antikoerper, peroxisome proliferator activated receptor gamma antikoerper, peroxisome proliferator activated receptor gamma L homeolog antikoerper, PPARG antikoerper, Pparg antikoerper, pparg.L antikoerper
    Hintergrund
    PPAR gamma(PPARG), which encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. Three subtypes of PPARs are known: PPAR-alpha, PPARdelta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described.
    Gen-ID
    5468
    Pathways
    MAPK Signalweg, Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, Regulation of Lipid Metabolism by PPARalpha, Positive Regulation of Endopeptidase Activity, Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation
Sie sind hier:
Kundenservice